why would you want to buy at $7.20 ?
To me $7.20 is far to high a price for a business that still has high fixed costs despite little forward earnings likely , and management or board are not showing they are prepared to take a salary cut in the presentation
- Forums
- ASX - By Stock
- FLT
- Equity raise process
Equity raise process, page-3
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FLT (ASX) to my watchlist
|
|||||
Last
$22.42 |
Change
-0.140(0.62%) |
Mkt cap ! $4.964B |
Open | High | Low | Value | Volume |
$22.57 | $22.60 | $22.40 | $4.249M | 188.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 324 | $22.42 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$22.43 | 761 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 285 | 22.430 |
6 | 848 | 22.420 |
8 | 936 | 22.410 |
4 | 737 | 22.400 |
4 | 1249 | 22.390 |
Price($) | Vol. | No. |
---|---|---|
22.450 | 560 | 9 |
22.460 | 1373 | 8 |
22.470 | 2597 | 9 |
22.480 | 839 | 4 |
22.490 | 353 | 2 |
Last trade - 11.01am 16/07/2024 (20 minute delay) ? |
Featured News
FLT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online